发明名称 ANTIDEPRESSANT
摘要 Protein kinase B activator comprises a benzofused azole compound (I). Protein kinase B activator comprises a benzofused azole compound of formula (I), its salt or prodrugs. [Image] R 1-R 3H, hydrocarbyl or heterocyclyl, or CR 1R 2a ring; W : optionally substituted benzofused 5-7 membered nitrogenous heterocyclyl attached via N, NR 4R 5 or R 4cX; R 4optionally substituted aliphatic hydrocarbyl (substituted by aromatic group) or acyl (substituted by aromatic group); R 5H, 1-6C alkyl or acyl; R 4caromatic group, aliphatic hydrocarbyl or acyl; X : O or S; Y : O, S or NH, and D : optionally substituted benzene. ACTIVITY : Antidepressant; Tranquilizer; Neuroprotective; Nootropic; Antiparkinsonian; Anticonvulsant; Antidiabetic; CNS-Gen.; Cerebroprotective; Antimicrobial-Gen.; Anti-HIV; Muscular-Gen.; Ophthalmological; Nephrotropic; Hepatotropic; Antiinflammatory; Antialcoholic; Osteopathic. MECHANISM OF ACTION : Protein-Kinase-Stimulator-B. In assays using rat neurons, (+)-5,6-dimethoxy-2-[2,2,4,6,7-heptamethyl-3-(4-methylphenyl)-2,3-dihydro-1-benzofuran-5-yl]isoindoline (Ia) at 1000 nM activated protein kinase B (Akt).
申请公布号 EP1481679(B1) 申请公布日期 2010.08.25
申请号 EP20030707169 申请日期 2003.02.28
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED 发明人 OHKAWA, SHIGENORI;MIYAMOTO, MASAOMI
分类号 A61K31/4035;A61P25/00;A61P25/14;A61P25/16;A61P25/22;A61P25/24;A61P25/28;A61P43/00;C07D307/79;C07D405/04;C07D405/12;C07D409/12;C07D491/04;C07D491/056;C07D491/10;C07D491/107 主分类号 A61K31/4035
代理机构 代理人
主权项
地址